News
After undergoing several tests, she was diagnosed with myasthenia gravis (MG), a rare autoimmune disease ... A chest CT scan is also done to detect any tumour or enlargement of the thymus gland, which ...
Hosted on MSN17d
Living with myasthenia gravis, a rare but manageable conditionAfter undergoing several tests, she was diagnosed with myasthenia gravis (MG), a rare ... to detect any tumour or enlargement of the thymus gland, which is often associated with MG.
Myasthenia gravis (MG) is a rare, chronic autoimmune disorder that disrupts the communication between nerves and muscles. It ...
Ultomiris (ravulizumab-cwvz) is a brand-name infusion prescribed for myasthenia gravis. This article covers topics such as side effects, dosage, and how Ultomiris works. Ultomiris is an ...
MG-ADL scores improved, indicating enhanced daily functioning for patients with myasthenia gravis. Limitations include potential coding errors, selection biases, and missing clinical data ...
Nicholas J. Silvestri, MD, describes how this year’s AAN meeting highlighted significant advances in myasthenia gravis, including improved diagnostics through cell-based assays that enhance ...
The FDA has approved Alexion's Soliris for use in patients with treatment resistant generalised Myasthenia gravis (gMG), making it the first new therapy for the condition in 60 years.
The FDA has approved Johnson & Johnson’s nipocalimab (Imaavy) for adults and paediatric patients 12 years of age and older with generalized myasthenia gravis (gMG) and anti-acetylcholine ...
Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results